A
ANTERIOS
Biotech & Life Sciences · New York City, United States · Founded 2006
Innovative biopharmaceutical solutions tackling the toughest health challenges with a focus on impactful treatments MoreLess
Anterios Inc. operates in the biopharmaceutical industry, focusing on developing innovative treatments for some of the most challenging health conditions. The company serves a diverse range of clients, including healthcare providers, hospitals, and patients in need of advanced medical solutions. Anterios Inc. operates in a highly regulated market, adhering to stringent legal and ethical standards to ensure the safety and efficacy of its products. The business model is centered around research and development (R&D), where significant investments are made to discover and develop new drugs. Revenue is generated through the sale of these pharmaceutical products, licensing agreements, and partnerships with other healthcare organizations. The company aims to make a remarkable impact on people's lives by not only treating diseases but also improving overall health outcomes. Keywords: biopharmaceutical, innovative treatments, healthcare providers, hospitals, patients, regulated market, R&D, drug discovery, licensing, health outcomes.
Company overview
ANTERIOS company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2006
- Headquarters
- New York City, United States
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 25.7
Valuation & funding
ANTERIOS funding history
Company financing events and reported valuations.
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 3 |
| 2025 | 3 |
| 2024 | 3 |
| 2023 | 3 |
| 2022 | 3 |
| 2021 | 3 |
| 2020 | 5 |
Growth signals
ANTERIOS website traffic
Latest recorded traffic for ANTERIOS is 0 monthly website visits. ANTERIOS's team grew 0% over the past year.
Comparisons
ANTERIOS compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
ANTERIOS's talent
Source: Dealroom Talent Intelligence.
Investors
3 investors on ANTERIOS's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where ANTERIOS has talent and traffic
In the news
Latest news about ANTERIOS
Recent press, funding announcements, and product moves mentioning ANTERIOS — open to read from the original sources.
Market sentiment
What the market is saying about ANTERIOS
An AI-synthesized read of the highest-engagement posts about ANTERIOS on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ANTERIOS’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.